Enfusion (ENFN) Competitors

Workiva (NYSE:WK) and Enfusion (NYSE:ENFN) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

Is WK or ENFN more profitable?

Enfusion has a net margin of 1.70% compared to Workiva's net margin of -7.15%. Enfusion's return on equity of 6.67% beat Workiva's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Workiva	-7.15%	N/A	-3.58%
Enfusion	1.70%	6.67%	4.86%

Do institutionals and insiders hold more shares of WK or ENFN?

92.2% of Workiva shares are owned by institutional investors. Comparatively, 81.1% of Enfusion shares are owned by institutional investors. 3.9% of Workiva shares are owned by company insiders. Comparatively, 36.4% of Enfusion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts prefer WK or ENFN?

Workiva presently has a consensus price target of $103.20, suggesting a potential upside of 11.98%. Enfusion has a consensus price target of $9.40, suggesting a potential downside of 4.95%. Given Workiva's stronger consensus rating and higher possible upside, equities research analysts clearly believe Workiva is more favorable than Enfusion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Workiva	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
Enfusion	3 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.60

Does the MarketBeat Community prefer WK or ENFN?

Workiva received 393 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 65.58% of users gave Workiva an outperform vote while only 18.75% of users gave Enfusion an outperform vote.

Company	Underperform	Outperform
Workiva	Outperform Votes 402 65.58%	Underperform Votes 211 34.42%
Enfusion	Outperform Votes 9 18.75%	Underperform Votes 39 81.25%

Which has better earnings and valuation, WK or ENFN?

Enfusion has lower revenue, but higher earnings than Workiva. Workiva is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Workiva	$630.04M	8.10	-$127.53M	-$0.92	-100.17
Enfusion	$195.16M	6.52	$6.03M	$0.04	247.25

Does the media refer more to WK or ENFN?

In the previous week, Workiva and Workiva both had 5 articles in the media. Enfusion's average media sentiment score of 1.29 beat Workiva's score of 1.21 indicating that Enfusion is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Workiva	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enfusion	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, WK or ENFN?

Workiva has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500.

Summary

Workiva beats Enfusion on 9 of the 17 factors compared between the two stocks.